Report Highlights
Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Drug Type: Anti Diabetics drugs; Anti-Thyroid Drugs; Antiobesity; Others (Hypopituitarism, Hypoadrenalism)
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
4) By Route Of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Novo Nordisk; Eli Lilly And Company; Novartis AG; Sanofi S.A.; Merck & Co.; GlaxosmithKline; Johnson & Johnson
Metabolic Disorders Drugs Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Metabolic Disorders Drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider metabolic disorders drugs market, and compares it with other markets.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
- The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.
Scope
Markets Covered:
- By Type: Pharmaceutical Drugs; Biologics
- By Drug Type: Anti Diabetics drugs; Anti-Thyroid Drugs; Antiobesity; Others (Hypopituitarism, Hypoadrenalism)
- By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
- By Route Of Administration: Oral; Parenteral; Others
- By Drug Classification: Branded Drugs; Generic Drugs
- By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Companies Mentioned: Novo Nordisk; Eli Lilly And Company; Novartis AG; Sanofi S.A.; Merck & Co.
Metrics Covered: Number of Enterprises; Number of Employees
Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Historic Market Growth, Value ($ Billion)
- Table 2 : Forecast Market Growth, Value ($ Billion)
- Table 3 : Global Metabolic Disorders Drugs Market, 2021, By Region, Value ($ Billion)
- Table 4 : Global Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
- Table 5 : Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
- Table 6 : Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 7 : Global Metabolic Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 8 : Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 9 : Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 10 : Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 11 : Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Table 12 : Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
- Table 13 : Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2016-2026, Global
- Table 14 : Asia-Pacific, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 15 : Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 16 : Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 17 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
- Table 18 : Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 19 : China Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 20 : China Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 21 : Australia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 22 : Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 23 : Hong Kong Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 24 : India Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 25 : India Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 26 : Indonesia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 27 : Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 28 : Japan Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 29 : Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 30 : Malaysia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 31 : New Zealand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 32 : Philippines Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 33 : Singapore Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 34 : South Korea Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 35 : Thailand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 36 : Vietnam Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 37 : Western Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 38 : Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 39 : Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 40 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
- Table 41 : Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 42 : Austria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 43 : Belgium Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 44 : Denmark Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 45 : Finland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 46 : France Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 47 : France Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 48 : Germany Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 49 : Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 50 : Ireland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 51 : Italy Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 52 : Netherlands Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 53 : Norway Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 54 : Portugal Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 55 : Spain Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 56 : Sweden Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 57 : Switzerland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 58 : UK Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 59 : UK Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 60 : Eastern Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 61 : Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 62 : Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 63 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
- Table 64 : Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 65 : Czech Republic Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 66 : Poland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 67 : Romania Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 68 : Russia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 69 : Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 70 : North America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 71 : North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 72 : North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 73 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, North America Countries
- Table 74 : North America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 75 : Canada Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 76 : Mexico Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 77 : USA Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 78 : USA Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 79 : South America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 80 : South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 81 : South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 82 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, South America Countries
- Table 83 : South America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 84 : Argentina Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 85 : Brazil Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 86 : Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 87 : Chile Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 88 : Colombia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 89 : Peru Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 90 : Venezuela Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 91 : Middle East, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 92 : Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 93 : Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 94 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Middle East Countries
- Table 95 : Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 96 : Saudi Arabia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 97 : Israel Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 98 : Turkey Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 99 : UAE Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 100 : Africa, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Table 101 : Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Table 102 : Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Table 103 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Africa Countries
- Table 104 : Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 105 : Egypt Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 106 : Nigeria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 107 : South Africa Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Table 108 : Novo Nordisk Financial Performance
- Table 109 : Eli Lilly And Company Financial Performance
- Table 110 : Novartis AG Financial Performance
- Table 111 : Sanofi S.A Financial Performance
- Table 112 : Merck & Co Financial Performance
- Table 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
- Table 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
- Table 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
- Table 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
- Table 117 : Global Metabolic Disorders Drugs Market In 2026- Growth Countries
- Table 118 : Global Metabolic Disorders Drugs Market In 2026- Growth Segments
- Table 119 : Global Metabolic Disorders Drugs Market In 2026- Growth Strategies
- Figure 1 : Historic Market Growth, Value ($ Billion)
- Figure 2 : Forecast Market Growth, Value ($ Billion)
- Figure 3 : Global Metabolic Disorders Drugs Market, 2021, By Region, Value ($ Billion)
- Figure 4 : Global Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
- Figure 5 : Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region
- Figure 6 : Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 7 : Global Metabolic Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 8 : Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 9 : Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 10 : Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 11 : Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Figure 12 : Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
- Figure 13 : Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2016-2026, Global
- Figure 14 : Asia-Pacific, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 15 : Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 16 : Asia-Pacific, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 17 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
- Figure 18 : Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 19 : China Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 20 : China Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 21 : Australia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 22 : Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 23 : Hong Kong Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 24 : India Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 25 : India Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 26 : Indonesia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 27 : Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 28 : Japan Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 29 : Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 30 : Malaysia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 31 : New Zealand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 32 : Philippines Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 33 : Singapore Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 34 : South Korea Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 35 : Thailand Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 36 : Vietnam Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 37 : Western Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 38 : Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 39 : Western Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 40 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
- Figure 41 : Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 42 : Austria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 43 : Belgium Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 44 : Denmark Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 45 : Finland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 46 : France Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 47 : France Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 48 : Germany Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 49 : Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 50 : Ireland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 51 : Italy Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 52 : Netherlands Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 53 : Norway Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 54 : Portugal Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 55 : Spain Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 56 : Sweden Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 57 : Switzerland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 58 : UK Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 59 : UK Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 60 : Eastern Europe, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 61 : Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 62 : Eastern Europe, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 63 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
- Figure 64 : Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 65 : Czech Republic Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 66 : Poland Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 67 : Romania Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 68 : Russia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 69 : Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 70 : North America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 71 : North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 72 : North America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 73 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, North America Countries
- Figure 74 : North America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 75 : Canada Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 76 : Mexico Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 77 : USA Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 78 : USA Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 79 : South America, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 80 : South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 81 : South America, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 82 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, South America Countries
- Figure 83 : South America Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 84 : Argentina Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 85 : Brazil Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 86 : Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 87 : Chile Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 88 : Colombia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 89 : Peru Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 90 : Venezuela Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 91 : Middle East, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 92 : Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 93 : Middle East, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 94 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Middle East Countries
- Figure 95 : Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 96 : Saudi Arabia Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 97 : Israel Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 98 : Turkey Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 99 : UAE Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 100 : Africa, Metabolic Disorders Drugs Market, 2021, By Country, Value ($ Billion)
- Figure 101 : Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
- Figure 102 : Africa, Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
- Figure 103 : Per Capita Average Metabolic Disorders Drugs Expenditure, 2016-2026, Africa Countries
- Figure 104 : Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 105 : Egypt Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 106 : Nigeria Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 107 : South Africa Metabolic Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
- Figure 108 : Novo Nordisk Financial Performance
- Figure 109 : Eli Lilly And Company Financial Performance
- Figure 110 : Novartis AG Financial Performance
- Figure 111 : Sanofi S.A Financial Performance
- Figure 112 : Merck & Co Financial Performance
- Figure 113 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
- Figure 114 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
- Figure 115 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
- Figure 116 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
- Figure 117 : Global Metabolic Disorders Drugs Market In 2026- Growth Countries
- Figure 118 : Global Metabolic Disorders Drugs Market In 2026- Growth Segments
- Figure 119 : Global Metabolic Disorders Drugs Market In 2026- Growth Strategies
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Metabolic Disorders Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
Including: 1) By Type: Anti Diabetics drugs; Anti-Thyroid Drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Sanofi S.A; Novo Nordisk A/S; AstraZeneca ...
Metabolic Disorders Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery
Including: Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
The global metabolic disorders drugs market is expected to grow from $145.8 billion in 2019 to $150.4 billion in 2020 at a CAGR of 3.15%, despite the economic slowdown across countries owing to the pandemic outbreak. The market is then expected to recover and grow at a CAGR of 7.78% ...
Metabolic Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
Including: 1) By Type: Anti Diabetics drugs; Anti-Thyroid drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Sanofi S.A; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson; ...
Metabolic Disorders Drugs Global Market Report 2019
Including: Anti Diabetics drugs, Anti-Thyroid drugs, Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
Covering: Sanofi S.A, Novo Nordisk A/S, AstraZeneca Plc, Johnson & Johnson, Merck & Co
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More